Blog - Page 5220 of 5612

TuesdayJul 10, 2007 3:58 am

Cord Blood America, Inc. (CBAI.OB) Subsidiary’s Experienced Team and History Positions the Company to Reach Thousands of Families

Cord Blood America’s Subsidiary, CorCell, is a licensed and accredited cord blood company who has been dedicated to its work since 1995. Their stem-cell harvesting procedure is preferred by obstetricians for its safe, simple, and uncomplicated method. The company began in Pennsylvania as the first private cord blood company licensed for umbilical cord blood collection and is now a leader in the industry. The precious stem-cells are stored in its private laboratory which is both internationally known and AABB accredited. CorCell is focused on helping families protect future wellness, and will achieve its mission through educating and promoting the value…

MondayJul 09, 2007 6:49 pm

Fearless International (FRLE.OB) and Porsche Create Luxury Yacht

Shares of Fearless International (OTCBB: FRLE) climbed 2 cents, nearly 5 percent, to 45 cents this afternoon. The company is collaborating with Porsche Design Studio Austria to design custom yachts, combining marine and automotive characteristics to produce luxurious 28-150 feet water crafts.The first model, Fearless 28, hit the water February 28, 2007 - in the next three years, the company will unleash the 44, 68, 125 and 150 models. "To give you an idea of yachts and the way we're designing them with the Porsche design team, for a 125-foot yacht with a 26-foot beam, you'll be able to cruise…

MondayJul 09, 2007 6:49 pm

Top Closers with Big News

Every public company loves to put out good news and see the reflection in its stock price. The following three companies released positive news of some kind today or late yesterday and then watched as their stock prices closed very strong.Northwest Biotherapuetics Inc. (OTCBB: NWBO) announced today that they received authorization for use from the Swiss Institute of Public Health to make DCVax-Brain commercially available for treatment of brain cancer in Switzerland. Northwest intends to make the product available to patients in the 3rd quarter of 2007. The stock price for Northwest is up $5.23 to $7.33, which is up…

MondayJul 09, 2007 6:49 pm

AmeriFirst Lawyer Denouces SEC Allegations

If you've been following the recent activity in the Securities and Exchange Commission (SEC), then you know all about the SEC's recent scrutiny of Texas-based bank holdings company AmeriFirst. In a complaint filed Monday, July 2, the SEC leveled numerous accusations of investor fraud and financial mismanagement against the company, claiming that the company's investment opportunities "attracted investors with false promises of safety," and that company management used "much of their victim's money for their personal benefit." The SEC then filed an emergency action against the company to halt AmeriFirst's offering of securities - Secured Debt Obligations, or SDOs -…

MondayJul 09, 2007 6:49 pm

Global Resource Corporation (GBRC.OB) Announces Results from Energy Conversion Engine

Medical news always grabs attention in the stock community, especially when it involves cancer. That's why it's no surprise that share prices for Northwest Biotherapeautics Inc. (OTCBB: NWBO) skyrocketed a whopping 135 percent by midday after the company announced that it had developed the world's first commercially available brain cancer vaccine.According to a recent Northwest statement, the company's DCVax-Brain platform technology has been approved for commercial use in Switzerland, making it the first commercially available therapeutic vaccine for brain cancer victims. The statement claims that both newly diagnosed and recurrent brain cancer patients treated with DCVax-Brain had "more than double"…

MondayJul 09, 2007 6:49 pm

Northwest Biotherapeautics Inc (NWBO.OB) Shares Skyrocket with News of Cancer Vaccine

MondayJul 09, 2007 6:49 pm

CardioVascular BioTherapeutics Inc (CVBT.OB) Puts New Technology to the Test to Halt Heart Disease

Shares of CardioVascular BioTherapeutics Inc. (OTCBB: CVBT) rose 16.3 percent Friday to $1.07 due to highlights of its new angiogenesis treatment for those suffering from heart disease.Cardiovascular disease is no doubt a big issue for not only those inflicted with it, but also for a highly scrutinized healthcare system, due to the cost of necessary treatments. This disease strikes over 36 percent of the population in the U.S., resulting in 2,400 deaths each day. With this in mind, people in the medical industry have been waiting a long time for a better approach to angiogenesis treatment, which is the growth…

MondayJul 09, 2007 6:49 pm

RBID.com (RBID.PK) to Expand Horizons

Share prices for technology marketing company RBID.com Inc. (Pink Sheets: RBID) went up 28 percent today, thanks in large part to a number of changes the company is undertaking to make its services better.According to the company's CEO, Alan Rothman, the majority of these changes include new acquisitions and new products. "We have developed a marketing and sales licensing agreement for Simply Budgets, a forward-looking financial program," Rothman said. "It got raves in Australia and England, and we got the sales and marketing rights for that. And we're now developing a Web-based solution based on the use of that software…

MondayJul 09, 2007 6:19 pm

Knobias, Inc. (KNBS.OB) Leads the Competition with Its Wide Range of Financial Information

Knobias has established itself in the industry as a unique and competent company which has invented new ways to consolidate, organize and analyze financial information. The financial IT company remains on the cutting edge by offering solutions to maximize profitability, regardless of investment strategy. Knobias produces relevant, timely, and actionable stock market content with faithfulness that visitors can depend on. Since the company’s beginning in 1999, Knobias has stayed true to its mission by exposing small-cap investors to the truth surrounding small-cap investments. Let us hear your thoughts below:

MondayJul 09, 2007 3:39 pm

SigmaTel (SGTL) Increases 2Q Revenue Prediction

SigmaTel Inc. (NASDAQ: SGTL) announced today a revision in its financial outlook for June 2007. SigmaTel expects that revenue for the second quarter will now be in the range of $30 million to $31 million, which is higher than previously expected amounts of $24 million to $28 million.Although the original revenue expectations were greater than last month's generated revenue, in the last quarter SigmaTel was able to generate about $22.02 million. The new expectations will increase second-quarter revenues by about $8 million dollars, an increase from last quarter of about 36 percent. This news has helped project the company's stock…

Site Search

Company Search

Cord Blood America, Inc. (CBAI.OB) Subsidiary’s Experienced Team and History Positions the Company to Reach Thousands of Families

Fearless International (FRLE.OB) and Porsche Create Luxury Yacht

Top Closers with Big News

AmeriFirst Lawyer Denouces SEC Allegations

Global Resource Corporation (GBRC.OB) Announces Results from Energy Conversion Engine

Northwest Biotherapeautics Inc (NWBO.OB) Shares Skyrocket with News of Cancer Vaccine

CardioVascular BioTherapeutics Inc (CVBT.OB) Puts New Technology to the Test to Halt Heart Disease

RBID.com (RBID.PK) to Expand Horizons

Knobias, Inc. (KNBS.OB) Leads the Competition with Its Wide Range of Financial Information

SigmaTel (SGTL) Increases 2Q Revenue Prediction

Market Basics

Newsletter Publishers

Public Companies